Compound: PF-562271

Drug Target: FAK, FAK2

Drug Target pathway: Cytoskeleton

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.